Literature DB >> 21907199

Mesd is a general inhibitor of different Wnt ligands in Wnt/LRP signaling and inhibits PC-3 tumor growth in vivo.

Cuihong Lin1, Wenyan Lu, Ling Zhai, Traci Bethea, Kristy Berry, Zhican Qu, William R Waud, Yonghe Li.   

Abstract

Mesd is a specialized chaperone for Wnt co-receptor low-density lipoprotein receptor-related protein-5 (LRP5) and LRP6, which contain four β-propeller/epidermal growth factor modules, named E1 to E4 from N- to C-terminal, in their extracellular domains. Herein, we demonstrated that recombinant Mesd protein is a general Wnt inhibitor that blocks Wnt/β-catenin signaling induced not only by LRP6 E1-E2-binding Wnts but also by LRP6 E3-E4-binding Wnts. We also found that Mesd suppressed Wnt/β-catenin signaling induced by Wnt1 in prostate cancer PC-3 cells, and inhibited tumor growth in PC-3 xenograft model. Our results indicate that Mesd is a universal inhibitor of Wnt/LRP signaling on the cell surface.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21907199      PMCID: PMC3183310          DOI: 10.1016/j.febslet.2011.08.046

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  31 in total

Review 1.  Wnt signaling in stem and cancer stem cells.

Authors:  Peter Wend; Jane D Holland; Ulrike Ziebold; Walter Birchmeier
Journal:  Semin Cell Dev Biol       Date:  2010-09-15       Impact factor: 7.727

2.  Mesd is a universal inhibitor of Wnt coreceptors LRP5 and LRP6 and blocks Wnt/beta-catenin signaling in cancer cells.

Authors:  Wenyan Lu; Chia-Chen Liu; Jaideep V Thottassery; Guojun Bu; Yonghe Li
Journal:  Biochemistry       Date:  2010-06-08       Impact factor: 3.162

3.  Mesd encodes an LRP5/6 chaperone essential for specification of mouse embryonic polarity.

Authors:  Jen-Chih Hsieh; Lance Lee; Liqun Zhang; Stephen Wefer; Kristen Brown; Charles DeRossi; Mary E Wines; Thomas Rosenquist; Bernadette C Holdener
Journal:  Cell       Date:  2003-02-07       Impact factor: 41.582

4.  Boca, an endoplasmic reticulum protein required for wingless signaling and trafficking of LDL receptor family members in Drosophila.

Authors:  Joaquim Culi; Richard S Mann
Journal:  Cell       Date:  2003-02-07       Impact factor: 41.582

5.  FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells.

Authors:  Santosh Gupta; Kristiina Iljin; Henri Sara; John Patrick Mpindi; Tuomas Mirtti; Paula Vainio; Juha Rantala; Kalle Alanen; Matthias Nees; Olli Kallioniemi
Journal:  Cancer Res       Date:  2010-08-16       Impact factor: 12.701

6.  Inhibition of tumorigenesis driven by different Wnt proteins requires blockade of distinct ligand-binding regions by LRP6 antibodies.

Authors:  Seth A Ettenberg; Olga Charlat; Michael P Daley; Shanming Liu; Karen J Vincent; Darrin D Stuart; Alwin G Schuller; Jing Yuan; Beatriz Ospina; John Green; Qunyan Yu; Renee Walsh; Sharon Li; Rita Schmitz; Holger Heine; Sanela Bilic; Lance Ostrom; Rebecca Mosher; K Felix Hartlepp; Zhenping Zhu; Stephen Fawell; Yung-Mae Yao; David Stover; Peter M Finan; Jeffery A Porter; William R Sellers; Ingo M Klagge; Feng Cong
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

7.  WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer.

Authors:  Christoph Wissmann; Peter Johannes Wild; Simone Kaiser; Stefan Roepcke; Robert Stoehr; Matthias Woenckhaus; Glen Kristiansen; Jen-Chih Hsieh; Ferdinand Hofstaedter; Arndt Hartmann; Ruth Knuechel; André Rosenthal; Christian Pilarsky
Journal:  J Pathol       Date:  2003-10       Impact factor: 7.996

8.  Wnt isoform-specific interactions with coreceptor specify inhibition or potentiation of signaling by LRP6 antibodies.

Authors:  Yan Gong; Eric Bourhis; Cecilia Chiu; Scott Stawicki; Venita I DeAlmeida; Bob Y Liu; Khanhky Phamluong; Tim C Cao; Richard A D Carano; James A Ernst; Mark Solloway; Bonnee Rubinfeld; Rami N Hannoush; Yan Wu; Paul Polakis; Mike Costa
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240

9.  The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of epithelial to mesenchymal transition.

Authors:  David S Yee; Yaxiong Tang; Xuesen Li; Zhongbo Liu; Yi Guo; Samia Ghaffar; Peter McQueen; Dash Atreya; Jun Xie; Anne R Simoneau; Bang H Hoang; Xiaolin Zi
Journal:  Mol Cancer       Date:  2010-06-23       Impact factor: 27.401

10.  Boca-dependent maturation of beta-propeller/EGF modules in low-density lipoprotein receptor proteins.

Authors:  Joaquim Culi; Timothy A Springer; Richard S Mann
Journal:  EMBO J       Date:  2004-03-11       Impact factor: 11.598

View more
  19 in total

1.  SRI36160 is a specific inhibitor of Wnt/β-catenin signaling in human pancreatic and colorectal cancer cells.

Authors:  Yonghe Li; Patsy G Oliver; Wenyan Lu; Vibha Pathak; Sivaram Sridharan; Corinne E Augelli-Szafran; Donald J Buchsbaum; Mark J Suto
Journal:  Cancer Lett       Date:  2016-12-30       Impact factor: 8.679

2.  Autosomal-Recessive Mutations in MESD Cause Osteogenesis Imperfecta.

Authors:  Shahida Moosa; Guilherme L Yamamoto; Lutz Garbes; Katharina Keupp; Ana Beleza-Meireles; Carolina Araujo Moreno; Eugenia Ribeiro Valadares; Sérgio B de Sousa; Sofia Maia; Jorge Saraiva; Rachel S Honjo; Chong Ae Kim; Hamilton Cabral de Menezes; Ekkehart Lausch; Pablo Villavicencio Lorini; Arsonval Lamounier; Tulio Canella Bezerra Carniero; Cecilia Giunta; Marianne Rohrbach; Marco Janner; Oliver Semler; Filippo Beleggia; Yun Li; Gökhan Yigit; Nadine Reintjes; Janine Altmüller; Peter Nürnberg; Denise P Cavalcanti; Bernhard Zabel; Matthew L Warman; Debora R Bertola; Bernd Wollnik; Christian Netzer
Journal:  Am J Hum Genet       Date:  2019-09-26       Impact factor: 11.025

3.  Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells.

Authors:  Wenyan Lu; Cuihong Lin; Yonghe Li
Journal:  Cell Signal       Date:  2014-03-06       Impact factor: 4.315

4.  Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells.

Authors:  Wenyan Lu; Cuihong Lin; Taj D King; Honghong Chen; Robert C Reynolds; Yonghe Li
Journal:  Cell Signal       Date:  2012-07-20       Impact factor: 4.315

5.  Salinomycin suppresses LRP6 expression and inhibits both Wnt/β-catenin and mTORC1 signaling in breast and prostate cancer cells.

Authors:  Wenyan Lu; Yonghe Li
Journal:  J Cell Biochem       Date:  2014-10       Impact factor: 4.429

Review 6.  WNT signalling in prostate cancer.

Authors:  Virginia Murillo-Garzón; Robert Kypta
Journal:  Nat Rev Urol       Date:  2017-09-12       Impact factor: 14.432

7.  Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer.

Authors:  Jasmine Miller-Kleinhenz; Xiangxue Guo; Weiping Qian; Hongyu Zhou; Erica N Bozeman; Lei Zhu; Xin Ji; Y Andrew Wang; Toncred Styblo; Ruth O'Regan; Hui Mao; Lily Yang
Journal:  Biomaterials       Date:  2017-10-21       Impact factor: 12.479

8.  Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway.

Authors:  Wenyan Lu; Cuihong Lin; Michael J Roberts; William R Waud; Gary A Piazza; Yonghe Li
Journal:  PLoS One       Date:  2011-12-16       Impact factor: 3.240

9.  Variability of Gene Expression Identifies Transcriptional Regulators of Early Human Embryonic Development.

Authors:  Yu Hasegawa; Deanne Taylor; Dmitry A Ovchinnikov; Ernst J Wolvetang; Laurence de Torrenté; Jessica C Mar
Journal:  PLoS Genet       Date:  2015-08-19       Impact factor: 5.917

10.  The C-terminal region Mesd peptide mimics full-length Mesd and acts as an inhibitor of Wnt/β-catenin signaling in cancer cells.

Authors:  Cuihong Lin; Wenyan Lu; Wei Zhang; Angelina I Londoño-Joshi; Donald J Buchsbaum; Guojun Bu; Yonghe Li
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.